US group transfers pharmaceutical production technology to Vietnam

Update: 08:53 | 11/01/2019

US-based Pfizer Group, one of the world's premier biopharmaceutical companies, has signed an agreement on the transfer of pharmaceutical production technology to Vietnamese enterprises, so first products are scheduled to be produced in 2020.

The information was made by the group’s Regional President for Asia and Emerging Markets Pierre Gaudreault in a meeting with Vietnam’s National Assembly Vice Chairman Phung Quoc Hien in Hanoi on January 10.

Pfizer Group Regional President, Asia and Emerging Markets, Pierre Gaudreault, National Assembly, Vice Chairman, Phung Quoc Hien, technology transfer, pharmaceutical production

National Assembly Vice Chairman Phung Quoc Hien (R) receives Pfizer Group's Regional President for Asia and Emerging Markets Pierre Gaudreault.

Pierre Gaudreault affirmed that the signing of the deal shows Pfizer’s commitment to long-term investment in Vietnam, thus contributing to the country’s pharmaceutical industry and applying technology with international standard in its drug production.

According to him, the group decided to invest in Vietnam as it sees potential of the Vietnamese market and its surrounding areas as well as the country’s open investment policies.

He pledged to share the group’s best experiences with Vietnamese enterprises while hoping that the Vietnamese Government will continue creating conditions on policies and procedures for the group to expand its presence in the country.

NA Vice Chairman Phung Quoc Hien stated that the transfer of technology is a breakthrough in the two sides’ cooperation. This not only is a good chance for Vietnam’s pharmaceutical producers to improve their capacity, but also helps Vietnamese people buy high-quality drugs at reasonable prices.

He suggested Pfizer study Vietnam’s climate to produce types of drugs that are suitable to Vietnamese and Southeast Asian markets.

He affirmed that Vietnam will facilitate investment of foreign enterprises, including Pfizer.


Bac Giang city boosts cooperation with Seo-gu district, RoK in medical tourism
(BGO)- The provincial Department of Foreign Affairs, municipal People’s Committee of Bac Giang city and Department of Culture, Sport and Tourism collaborated with Seo-gu district, Daejeon International Marketing Enterprise and a number of hospitals and medical institutions from Bac Giang and Daejeon city to organize a promotional conference on medical tourism called HEALING SONG 2018 on November 7.
Japanese doctors provide medical examination and gifts to victims of Agent Orange
(BGO) – A delegation of Japanese doctors on October 19 – 20 visited the northern province of Bac Giang to provide medical examination and present gifts to local victims of Agent Orange (AO victims).
New centre to be built to support medical treatment for dioxin victims
The National Steering Committee for Settlement of Post-war Unexploded Ordnance and Toxic Chemical Consequences plans to build a centre providing medical support for victims of toxic chemicals including dioxin during the period from 2018 to 2020. 
Experts discuss modern medical payments in Vietnam
Domestic and international experts gathered at a workshop held by the Ministry of Health and the World Bank in Hanoi on October 9, to discuss measures to boost diagnosis-related group (DRG) payments in Vietnam.
E-medical records to be deployed nationwide by 2021
By 2021, Vietnam will deploy electronic medical records in all medical examination and treatment establishments nationwide, heard a conference on smart healthcare, held by the Ministry of Health (MoH), on September 19.

Source: VNA

Bình luận mới vừa được thêm vào. Click để xem
Mới nhấtHay nhấtXếp theo: